1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Polyneuropathies Global Clinical Trials Review, H2, 2014

Polyneuropathies Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Polyneuropathies Global Clinical Trials Review, H2, 2014" provides data on the Polyneuropathies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polyneuropathies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polyneuropathies. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Polyneuropathies Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Polyneuropathies 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Polyneuropathies to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Polyneuropathies to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Polyneuropathies 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Polyneuropathies Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
NeurogesX, Inc. 33
Clinical Trial Overview of NeurogesX, Inc. 33
CSL Limited 34
Clinical Trial Overview of CSL Limited 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
LFB S.A. 36
Clinical Trial Overview of LFB S.A. 36
Grifols, S.A. 37
Clinical Trial Overview of Grifols, S.A. 37
Biogen Idec Inc. 38
Clinical Trial Overview of Biogen Idec Inc. 38
Eisai Co., Ltd. 39
Clinical Trial Overview of Eisai Co., Ltd. 39
E. Merck KG 40
Clinical Trial Overview of E. Merck KG 40
Astellas Pharma Inc. 41
Clinical Trial Overview of Astellas Pharma Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Odense University Hospital 42
Clinical Trial Overview of Odense University Hospital 42
National Center for Research Resources 43
Clinical Trial Overview of National Center for Research Resources 43
Assistance Publique - Hopitaux de Paris 44
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 44
Aarhus University 45
Clinical Trial Overview of Aarhus University 45
Erasmus MC 46
Clinical Trial Overview of Erasmus MC 46
Skane University Hospital 47
Clinical Trial Overview of Skane University Hospital 47
The University of New South Wales 48
Clinical Trial Overview of The University of New South Wales 48
Medical University of Vienna 49
Clinical Trial Overview of Medical University of Vienna 49
Oregon Health and Science University 50
Clinical Trial Overview of Oregon Health and Science University 50
Rigshospitalet 51
Clinical Trial Overview of Rigshospitalet 51
Five Key Clinical Profiles 52
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 87

List of Tables
Polyneuropathies Therapeutics, Global, Clinical Trials by Region, 2014* 7
Polyneuropathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Polyneuropathies Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Polyneuropathies Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Polyneuropathies Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Polyneuropathies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Polyneuropathies Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Polyneuropathies to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Polyneuropathies to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Polyneuropathies Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Polyneuropathies Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Polyneuropathies Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Polyneuropathies Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Polyneuropathies Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Polyneuropathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Polyneuropathies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Polyneuropathies Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Polyneuropathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Polyneuropathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 32
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014* 33
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014* 34
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 35
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by LFB S.A., 2014* 36
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2014* 37
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 38
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 39
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 40
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 41
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 42
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 43
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 44
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 45
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 46
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Skane University Hospital, 2014* 47
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014* 48
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 49
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 50
Polyneuropathies Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 51

List of Figures
Polyneuropathies Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Polyneuropathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Polyneuropathies Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Polyneuropathies Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Polyneuropathies Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Polyneuropathies Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Polyneuropathies Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Polyneuropathies to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Polyneuropathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Polyneuropathies to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Polyneuropathies Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Polyneuropathies Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Polyneuropathies Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Polyneuropathies Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Polyneuropathies Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Polyneuropathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Polyneuropathies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Polyneuropathies Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Polyneuropathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Polyneuropathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.